Prout Samantha Whiteman

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(8%)< 1%(17%)0%0%
Sale Success Rate2 of 52 of 50 of 50 of 50 of 5
Drugs » Biotechnology

Chief Accounting Officer:

Holdings: 80.95K shares

Sentiment

Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--